Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LunInfection_FDDXHSYY_20190823_mWGS

ABSTRACT: lung disease

TISSUE(S): ['lung']

DISEASE(S): ['lung Disease']

SUBMITTER: Liyun Yuan

PROVIDER: OEX00013131 | NODE | 2021-06-03

REPOSITORIES: NODE

ACCESS DATA

Json Xml

Similar Datasets

LC_ZGYXKXYZLYY_20190823_WES

Project description:lung disease

2021-06-03 | OEX00013150 | NODE

Mus musculus

Project description:Indium lung disease

| PRJDB4846 | ENA

Sickle Cell Disease mouse lung

Project description:Sickle Cell Disease mouse lung

| PRJNA472342 | ENA

Project description:Human respiratory disease lung microbiome

| PRJNA548310 | ENA

GNPS - Metabolome dynamics associated with CLAD disease progression

Project description:This project is about an untargeted metabolomic analysis in samples that come from chronic lung allograft dysfunction disease patients.

| MSV000085760 | GNPS

Genome-wide analysis of plasma exosomal microRNA in lung cancer

Project description:Purpose: To identify a panel of plasma exosomal miRNAs as potential biomarkers for lung cancer from the genome-wide set of currently known human miRNAs. Methods: Plasma samples from 4 lung cancer patients and 4 patients with benign lung disease were collected, and plasma exosomes were extracted by ultracentrifugation. Exosomal miRNA profiles were generated by deep sequencing based on Illumina NextSeq 500 platform. And differentially expressed exosomal miRNAs between lung cancer and benign lung disease were identified by edgeR with the default threshold of |log2 (fold change) | ≥ 1.5 and P-value < 0.05. Results: A total of 983 detectable exosomal miRNAs were analyzed to identify differentially expressed miRNAs between two groups. There were 6 significantly up-regulated miRNAs and 63 significantly down-regulated miRNAs in lung cancer cases when compared with benign lung disease. Conclusion: The comparative analysis of plasma exosomal miRNAs between lung cancer and benign lung diseases provided a reference for exploring potential biomarkers of lung cancer. And the clinical value of candidate exosomal miRNAs needs to be further verified in lung cancer clinical trials.

2025-02-04 | GSE196159 | GEO

Project description:pathogen that causes important lung disease

| PRJNA1266893 | ENA

Project description:Isolation of Burkholderia from lung disease

| PRJNA1033429 | ENA

GWAS in Fibrosing Interstitial Lung Disease

Project description:GWAS in Fibrosing Interstitial Lung Disease

| PRJNA248931 | ENA

Homo sapiens

Project description:GWAS in Fibrosing Interstitial Lung Disease

| PRJNA248932 | ENA